StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.75−0.07 (-3.98%)

Close on Nov 18, 2026Market cap $2.54MP/E –Yield –

Nexentis Technologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nexentis Technologies's revenue for the twelve months ending Sep 30, 2025 was $209.00K, up 19.2% year over year. For fiscal 2024 it was $210.00K, down 20.2% from the year before. The highest annual figure on record is $438.14K in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$210.00K-20.2%
FY2023Dec 31, 2023$263.00K-33.2%
FY2022Dec 31, 2022$394.00K-10.1%
FY2021Dec 31, 2021$438.14K+88.6%
FY2020Dec 31, 2020$232.27K+32.1%
FY2019Dec 31, 2019$175.82K-58.8%
FY2018Dec 31, 2018$426.59K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$2.00K-77.8%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$66.00K+50.0%
Q4 FY2024Dec 31, 2024$141.00K+33.8%
Q3 FY2024Sep 30, 2024$9.00K–
Q2 FY2024Jun 30, 2024$17.00K-53.6%
Q1 FY2024Mar 31, 2024$44.00K-63.6%
Q4 FY2023Dec 31, 2023$105.38K-53.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$36.61K+17.8%
Q1 FY2023Mar 31, 2023$121.01K+38.1%
Q4 FY2022Dec 31, 2022$224.06K+18.4%
Q3 FY2022Sep 30, 2022$51.23K-28.2%
Q2 FY2022Jun 30, 2022$31.08K-42.9%
Q1 FY2022Mar 31, 2022$87.63K-28.8%
Q4 FY2021Dec 31, 2021$189.30K+12.2%
Q3 FY2021Sep 30, 2021$71.36K–
Q2 FY2021Jun 30, 2021$54.40K–
Q1 FY2021Mar 31, 2021$123.07K+93.6%
Q4 FY2020Dec 31, 2020$168.71K+266.0%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$63.57K-51.0%
Q4 FY2019Dec 31, 2019$46.09K–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$129.73K–

More Nexentis Technologies figures

See a number that looks wrong?